文献
J-GLOBAL ID:201802245889932352
整理番号:18A0974565
転移性腎細胞癌または他の進行腫瘍患者におけるベバシズマブと併用したパゾパニブの第I相用量漸増試験【JST・京大機械翻訳】
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
著者 (11件):
Negrier Sylvie
(University Lyon, Universite Claude Bernard Lyon 1, Centre Leon Berard, Lyon, France)
,
Perol David
(Clinical Research and Innovation Department, Centre Leon Berard, Lyon, France)
,
Bahleda Rastislav
(DITEP -Departement d’Innovation Therapeutiques et Essais Precoces, Institut Gustave Roussy, Villejuif Cedex, France)
,
Hollebecque Antoine
(DITEP -Departement d’Innovation Therapeutiques et Essais Precoces, Institut Gustave Roussy, Villejuif Cedex, France)
,
Chatelut Etienne
(Institut Claudius Regaud, Inserm UMR1037 CRCT, Universite Paul-Sabatier, Toulouse, France)
,
Boyle Helen
(Medical Oncology Department, Centre Leon Berard, Lyon, France)
,
Cassier Philippe
(Medical Oncology Department, Centre Leon Berard, Lyon, France)
,
Metzger Severine
(Medical Oncology Department, Centre Leon Berard, Lyon, France)
,
Blanc Ellen
(Medical Oncology Department, Centre Leon Berard, Lyon, France)
,
Soria Jean-Charles
(University of Paris Sud, Orsay, Institut Gustave Roussy, Villejuif Cedex, France)
,
Escudier Bernard
(Department of Medical Oncology, Institut Gustave Roussy, Villejuif Cedex, France)
資料名:
BMC Cancer (Web)
(BMC Cancer (Web))
巻:
17
号:
1
ページ:
547
発行年:
2017年
JST資料番号:
U7305A
ISSN:
1471-2407
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)